| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/14/2009 | CN100450573C A method and process for controlling the temperature, pressure-and density profiles in dense fluid processes |
| 01/14/2009 | CN100450554C Medical adhesive composition, adhesive tape therefrom and endermic absorbed adhesive tape products |
| 01/14/2009 | CN100450549C Solubilization carrier for drug, its preparation method and application |
| 01/14/2009 | CN100450548C Oral patches containing pdacrilin resin composition and its preparing method |
| 01/14/2009 | CN100450547C Medicinal compositions for improving oral absorption |
| 01/14/2009 | CN100450544C Compound medicinal preparation for treating femur necrosis |
| 01/14/2009 | CN100450542C Formulation for a protein pharmaceutical without added human serum albumin (HSA) |
| 01/14/2009 | CN100450535C Chinese medicine for treating lumhardisc protrusion |
| 01/14/2009 | CN100450534C Medicine for treating hepatic fibrosis and preparation method thereof |
| 01/14/2009 | CN100450522C Medicine for treating chronic gastropathy and its prepn |
| 01/14/2009 | CN100450521C Impotence treating medicine and its preparing method |
| 01/14/2009 | CN100450518C Ready prepared Chinese medicine for treating epicophosis and sonitus |
| 01/14/2009 | CN100450514C Chinese medicine for treating bronchial asthma in acute attack stage and its prepn process |
| 01/14/2009 | CN100450510C Medicine for treating enuresis and preparation method thereof |
| 01/14/2009 | CN100450505C Chinese medicinal ointment for treating beriberi |
| 01/14/2009 | CN100450504C Medication for treating pharyngitis |
| 01/14/2009 | CN100450502C Active extract of lamtophlomis rotata and its preparing method and use |
| 01/14/2009 | CN100450501C Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 01/14/2009 | CN100450500C Medicinal composition for treating and preventing nasal sinusitis and preparing method |
| 01/14/2009 | CN100450496C Compound preparation of notoginseng and safflower for treating cardiovascular and cerebrovascular diseases |
| 01/14/2009 | CN100450494C Medicinal use of Aralia continentalis kitag |
| 01/14/2009 | CN100450493C Black fungus composite soft capsule and its preparing process |
| 01/14/2009 | CN100450491C An antibacterial antiinflammation pain-relieving tissue-regenerating medicine, its preparation method and use |
| 01/14/2009 | CN100450489C Huangyangning drop pills and preparation method |
| 01/14/2009 | CN100450488C Soft steroid compositions for use in dry powder inhalers |
| 01/14/2009 | CN100450487C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 01/14/2009 | CN100450486C Application of dipyridamole in preparation of anti-malignant tumor medicine |
| 01/14/2009 | CN100450484C Imiquimod turbid liquor and gelling agent thereof |
| 01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
| 01/14/2009 | CN100450482C Transdermaltherapeutic system containing a pramipexol active agent |
| 01/14/2009 | CN100450481C Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method |
| 01/14/2009 | CN100450480C Aquogel type thiamazole plaster preparation |
| 01/14/2009 | CN100450479C Medication in use for bacteriostasis and antiinflammation |
| 01/14/2009 | CN100450478C Pharmaceutical composition |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450476C Electrolyte complementary medical combination for injection |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/14/2009 | CN100450473C Aseptic medicinal composition |
| 01/14/2009 | CN100450472C Medical active agent patch optically less visible on skin |
| 01/14/2009 | CN100450471C Soft capsule of atovastatine salts and prepn. method therefor |
| 01/14/2009 | CN100450470C Rapid disintegrate tablet in oral and its preparation method |
| 01/14/2009 | CN100450469C Starch oral colon-target aqueous gel and its preparation method and use |
| 01/13/2009 | US7477938 Device for delivery of active agents to barrier membranes |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476694 Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles |
| 01/13/2009 | US7476693 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 01/13/2009 | US7476692 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 01/13/2009 | US7476689 Therapeutic compositions for intranasal administration which include KETOROLAC |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | US7476652 by addition of surfactants such as nonionic surfactants of the (poly)ethoxylated fatty acid type; storage stability to hydrophobic aggregation nuclei for several months under temperature stress |
| 01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
| 01/13/2009 | US7476403 Controlled release dosage form for a sparingly water soluble to insoluble drug, and a mixture of a low viscosity polymer and a higher viscosity polymer such as hydroxypropyl cellulose; clarithromycin for example; less food effect on bioavailability; side effect reduction |
| 01/13/2009 | US7476402 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 01/13/2009 | US7476401 Noncovalent interaction of a charged polypeptide with a surfactant of opposite charge to form a polypeptide-surfactant mixture; lyophilizing to form a dried salt complex; for delivering a polypeptide |
| 01/13/2009 | US7476400 Liposomes containing an oil phase comprising topical anestheic, a C14-C20 alcohol, an alkyl ester of a fatty acid, propylene glycol, and a polyoxyalkylene stearate. |
| 01/13/2009 | US7476399 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products |
| 01/13/2009 | US7476396 Composition for removing abnormal keratinous material |
| 01/13/2009 | US7476386 Mixed lipopeptide micelles for inducing an immune response |
| 01/13/2009 | US7476380 Using vitamin A and/or the derivatives and/or the esters for therapy and prophylaxis, side effect reduction |
| 01/13/2009 | US7476379 Animal oils/extracts (from Emu), bezoin, alkyl ester, allantoin, methylparaben, and propylparaben |
| 01/13/2009 | US7476224 Temperature responsive systems |
| 01/13/2009 | CA2605226C Nucleotide analog composition and synthesis method |
| 01/13/2009 | CA2470466C Combinations of viscoelastics for use during surgery |
| 01/13/2009 | CA2400312C Nutritional intervention composition for enhancing and extending satiety |
| 01/13/2009 | CA2395333C Hydrogel-driven drug dosage form |
| 01/13/2009 | CA2340118C Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 01/13/2009 | CA2315975C Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/13/2009 | CA2303770C Multilayered soft capsule for eliminating foul breath and process for producing the same |
| 01/13/2009 | CA2263750C Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype |
| 01/13/2009 | CA2241322C Sustained-release preparation and its production |
| 01/08/2009 | WO2009006527A1 Chemical modification of maleated fatty acids |
| 01/08/2009 | WO2009006466A1 Feeding regime for prevention of porcine enteropathic conditions |
| 01/08/2009 | WO2009006311A2 Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| 01/08/2009 | WO2009006299A2 Multi-particulate systems |
| 01/08/2009 | WO2009006130A2 Salt free hyaluronate ophthalmic solution |
| 01/08/2009 | WO2009006097A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/08/2009 | WO2009006095A2 Dual portion lozenge dosage form |
| 01/08/2009 | WO2009005923A1 In situ, liquid-activated film coated tablets and a process for making the same |
| 01/08/2009 | WO2009005814A2 Drug-delivery patch comprising a dissolvable layer and uses thereof |
| 01/08/2009 | WO2009005718A1 Polypeptide microparticles having sustained release characteristics, methods and uses |
| 01/08/2009 | WO2009005709A1 Polypeptide microparticles |
| 01/08/2009 | WO2009005613A2 Stable non-disintegrating dosage forms and method of making same |
| 01/08/2009 | WO2009005152A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel |
| 01/08/2009 | WO2009005044A1 Medicine packaging device |
| 01/08/2009 | WO2009004999A1 Seamless capsule |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004971A1 Prophylactic/therapeutic agent for articular rheumatism |
| 01/08/2009 | WO2009004873A1 Prostaglandin derivative-containing aqueous liquid agent |
| 01/08/2009 | WO2009004654A2 Modified release dosage form of sulfonylurea compound |
| 01/08/2009 | WO2009004649A2 Enteric coated pharmaceutical compositions |
| 01/08/2009 | WO2009004621A1 Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage |
| 01/08/2009 | WO2009004595A2 Enhancement of the efficacy of therapeutic proteins |
| 01/08/2009 | WO2009004592A1 Vancomycin compositions |
| 01/08/2009 | WO2009004467A1 Apparatus for making food items, in particular confectionery |
| 01/08/2009 | WO2009004440A2 Quick dissolve compositions of memantine hydrochloride |
| 01/08/2009 | WO2009004409A1 Preparations contaning microorganisms |
| 01/08/2009 | WO2009004310A1 Modified globin proteins with attenuated electron transport pathway |
| 01/08/2009 | WO2009004309A1 Modified globin proteins with altered electron transport pathway |